Are the anxiety levels of pediatric hematology-oncology patients different from healthy peers during the COVID-19 outbreak?

Basit Öğe Kaydı
dc.contributor.authorÇakıroğlu, Süleyman
dc.contributor.authorYeltekin, Ceren
dc.contributor.authorFışgın, Tunç
dc.contributor.authorÖner, Özlem B.
dc.contributor.authorAksoy, Başak A.
dc.contributor.authorBozkurt, Ceyhun
dc.date.accessioned2021-05-15T12:49:54Z
dc.date.available2021-05-15T12:49:54Z
dc.date.issued2020
dc.departmentTıp Fakültesi, Pediatrik Hematoloji ve Onkoloji Anabilim Dalıen_US
dc.description.abstractThe COVID-19 outbreak has caused anxiety among children with hematology-oncology disease and their families, as it has in every segment of society. In this study, we aimed to detect the anxiety levels of children with hematologic or oncologic disease and of their parents after the COVID-19 outbreak. The sample consisted of 15 patients aged 12 to 18 years receiving treatment in the Pediatric Hematology and Oncology Unit in Altinbaş University Medical Faculty Bahçelievler Medikalpark Hospital and 33 parents of the same unit patients aged between 6 and 18, and their 35 healthy peers and their parents. The State-Trait Anxiety Inventory was applied to participant children and their parents to evaluate their general anxiety and pandemic-related anxiety levels. Children with a hematology-oncology disease and their families were compared with healthy peers and their families. No significant difference was observed for pandemic-related anxiety levels (P>0.05). Both parent groups exhibited higher anxiety levels with regard to the pandemic than did their children (P<0.05). Children with hematology-oncology disease reported significantly higher trait anxiety levels when compared with healthy peers (P=0.01). The families of children who had not received stem cell transplantation had higher state and trait anxiety scores than the families of children who had received the transplantation (P<0.05). Even though they were in the high-risk group, children with a hematology-oncology disease and their families had pandemic-related anxiety levels comparable to those of healthy peers and their families. © 2020 Lippincott Williams and Wilkins. All rights reserved.en_US
dc.identifier.doi10.1097/MPH.0000000000001924
dc.identifier.issn1077-4114
dc.identifier.pmid32852396
dc.identifier.scopus2-s2.0-85091613498
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1097/MPH.0000000000001924
dc.identifier.urihttps://hdl.handle.net/20.500.12939/1141
dc.identifier.wosWOS:000668269300010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorFışgın, Tunç
dc.language.isoen
dc.publisherLippincott Williams and Wilkinsen_US
dc.relation.ispartofJournal of Pediatric Hematology/Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectCOVID-19 Outbreaken_US
dc.subjectmalignant Diseasesen_US
dc.subjectState-Trait Anxietyen_US
dc.titleAre the anxiety levels of pediatric hematology-oncology patients different from healthy peers during the COVID-19 outbreak?
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Cerrahi Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu